Skip to main content

Increasing Prevalence of Osteoarthritis to Augment the Viscosupplementation Market Growth

 


Viscosupplementation is a minimally invasive procedure that helps reduce joint pain and improves the functional condition of the osteoarthritic joint. It is a treatment in which a thick fluid named hyaluronate or hyaluronic acid is injected into the knee joint Hyaluronic acid is distributed throughout the body in epithelial, connective tissues, and neural tissues to promote better joint development and lubrication. Osteoarthritis is a type of arthritis that occurs when the flexible tissue at the ends of bones begins to wear down. Moreover, osteoarthritis is the most common form of arthritis in the world. It can be classified into 2 categories such as primary and secondary osteoarthritis.

Osteoarthritis is characterized by loss of function and degeneration of cartilage and tissues that cover the ends of the bones in a joint. There is not a complete cure for osteoarthritis, hyaluronic acid is thought to improve the lubricating properties of the synovial fluid, provide a more comfortable level of activity, improve mobility, and reduce the pain from osteoarthritis of the knee. The increasing prevalence of osteoarthritis is expected to increase the demand for viscosupplementation products, which is expected to drive the viscosupplementation market growth. According to the World Health Organization (WHO), around 9.6% of men and 18.0% of women aged 60 years and above have symptomatic osteoarthritis worldwide. However, the number is expected to increase due to the growing geriatric population and the obesity epidemic.

Moreover, novel biomimetic polymer viscosupplements are rapidly replacing in-development osteoarthritis joint injections, and thus, key players are focused on increasing research and development in biocompatible polymers. These polymers are widely used in the Food and Drug Administration (FDA) approved stents, surgical meshes, and contact lenses, and help prevent degradation associated with hyaluronate. Furthermore, the viscosupplementation market is expected to witness robust growth in 2021 with a somewhat recovery of emerging and developed economies from the global pandemic (COVID-19).

In terms of geography, the market is divided into six regions, such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa. Osteoarthritis is the most common joint disorder in the United States. The increasing prevalence of lifestyle-induced disorders, increasing demand for non-surgical treatments for osteoarthritis, and technological advances in the development of hyaluronic acid-based therapies are some of the factors expected to foster the viscosupplementation market growth. For instance, in 2019, Anika Therapeutics showcased HYALOFAST, a biodegradable, hyaluronic acid-based scaffold for cartilage repair at the 2019 International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting.

 

Comments

Popular posts from this blog

Virology Testing Market Detailed In New Research Report 2023

  Virology testing consist of diagnostic methods that help in early detection of the disease such as hepatitis, influenza, HIV, sexually transmitted disease, RCV, and other viral associated disease. Virology testing examines for detection of viral antigens, nucleic acids, and antibodies in the given sample in order to confirm the presence of particular viral infection. There are more than 100 viral diseases identified. Virology Testing Market- Market Dynamics Virology testing market is projected to witness significant growth during forecast period with rising prevalence of virus originated diseases such as flu, hepatitis, AIDS, and STDs, Ebola, Influenza based viral infections, severe acute respiratory syndrome from coronavirus, hemorrhagic fever etc. across world. Early and fast diagnosis of virus infection is very essential to start treatment course. According to the World Health Organization (WHO), January 2018 factsheet, all types of influenza in combination causes annual...

Epidermolysis Bullosa Therapeutics Market Is Booming Worldwide 2023-2028

  Epidermolysis bullosa is a group of rare inherited skin disorders that causes the skin to become very fragile. Any trauma or friction to the skin can cause painful blisters. The symptoms of epidermolysis bullosa include skin that blisters easily, blisters on hands and soles of the feet, thickened skin that may be scarred or change color over time, and thickening of the skin and nails. There are three types of epidermolysis bullosa which includes: ·          Epidermolysis bullosa simplex (EBS) – the most common type, which can range from mild, with a low risk of serious complications to severe ·          Dystrophic epidermolysis bullosa (DEB) – which can range from mild to severe ·          Junctional epidermolysis bullosa (JEB) – a rare form of epidermolysis bullosa that ranges from moderate to severe The type reflects where on the body the blistering ...

Immobilized Trypsin Market continues to witness major growth due to extensive applications in protein identification, protein interactions, and protein characterization

  Immobilized Trypsin is the trade name for colloidal silver. This insoluble substance is synthesized as a result of the interaction of an acid (hydrogen) and an alkaline (monohydrate) base. Colloidal silver has numerous applications in the medical world. For instance, in veterinary science, Immobilized Silver compounds are often administered to tissues to stimulate their growth, as well as to prevent or reduce tissue damage caused by injuries and other external factors. Colloidal silver has also been found to have anti-bacterial, anti-viral, and anti-fungal properties. The clinical significance of these properties is still being studied; however, Immobilized Silver is widely used as a bacterial colloid, a degradable component of water softeners, and as a wound dressing ingredient in various fields of medicine. Trypsin is an amino acid that is found in proteins like albumin and gelatin. Trypsin belongs to the PA family of serines, present in the intestines of all vertebrates, in ...